Hematology and Oncology
Home Hematology and Oncology
ACOG: Shared Decision-Making Key to Breast Cancer Screening
Critically important for patient's value, preferences be factored into process, ACOG leader says
Many With Advanced Cancer Want Secondary Germline Findings Info
Attitudes toward learning influenced by patients' personal disease experience, health status
Clonal Hematopoiesis Linked to Coronary Heart Disease
CHIP linked to coronary heart disease, myocardial infarction in humans; atherosclerosis in mice
1991-2014 Saw Minimal Change in Health Spending Per State
Recession and recovery, implementation of health reform impacted health care coverage
PSA Testing Frequency High in Control Arm of Screening Trial
Over 15 years of follow-up, considerable proportion of men undergo prostate-specific antigen testing
Weight-Loss Program Aids Black Breast Cancer Survivors
Community-based, interventionist-guided weight loss program efficacious for early-stage survivors
HCC Drops Beyond Five Years of Entecavir/Tenofovir Tx for Hep B
Older age, lower platelets at baseline and year five, liver stiffness ≥12 kPa linked to HCC development
Strategies Compared for Cancer Medication Submission Lags
Shorter submission lag for global trial, early-initiation bridging strategy vs late-initiation strategy
Family Hx, Mutation Position Key Variables in BRCA1/2 Cancer Risk
Study findings provide cancer risk patterns based on BRCA status using prospective data
Nivolumab Doesn’t Up PFS in Stage IV or Recurrent NSCLC
Findings in patients with previously untreated disease with PD-L1 expression level of ≥5 percent
